F18-FDG PET–CT in immune checkpoint inhibitor-associated acute interstitial nephritis: what is the diagnostic value?
In this biopsy-validated cohort, PET-CTs did not reliably distinguish ICI-AIN from other causes of AKI in patients receiving ICI therapy. Larger prospective studies are needed to validate these findings.
Authors
- Michael S. Bold
- Coraima Claudia Nava Chavez
- Omar Al Refai
- Nelson Leung
- Rafaella Maria da Cunha Lyrio
- Sandra M Herrmann
- Victor D Cuenca Narvaez
Institutions
- Mayo Clinic (US)
- Washington University in St. Louis (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2026-02-12
- DOI
- https://doi.org/10.1093/ckj/sfag042
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00